FDA Letter On X-ray Servicing Software Should Be Retracted - Petition
This article was originally published in The Gray Sheet
FDA's letter on servicing software, sent to manufacturers of diagnostic x-ray components Dec. 24, violates the agency's Good Guidance Practices and therefore should be retracted, the Washington, D.C. law firm of Hyman, Phelps & McNamara states in a Feb. 5 letter to FDA.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.